New oral anticoagulant shows promise in post-myocardial infarction patients
Asundexian 50 mg administered to post-myocardial infarction patients inhibits factor XIa by more than 90% with no significant increase in bleeding, according to late breaking research presented in a Hot Line session on 28 ...
Aug 29, 2022
0
4